top of page
banner-meds2.jpg

TRIPS FLEXIBILITIES

​Provides an overview of the different compulsory licensing regimes in the 38 countries members of the European Patent Convention. For each country, the document provides the legal basis, grounds for applying a compulsory license, the general procedure, and statistics and jurisprudence.

​KEI provides information regarding compulsory licensing, such as global norms and countries experiences, including the use of compulsory licensing in the United States, and compulsory licensing of medical patents in Europe, Latin America, Asia Pacific and Africa.

Updated monthly, the Parallel Distribution register give information on parallel distribution notices, which have been checked by the European Medicines Agency. The register promotes transparency about parallel distribution notices, and increases information which is available for national authorities, holders of marketing authorisation, parallel distributors, and wholesalers.

Database of international drug patent oppositions. Provides information including patent applications, patent office decisions, patent oppositions, and in which country(ies) related to selected drugs.

The database contains “instances when authorities have invoked, planned to invoke, or have been asked to invoke a TRIPS flexibility for public health reasons, in particular access to medicines.” In particular the database includes compulsory licensing, patent exceptions, parallel import, and the Least Developed Country transition provisions.​

Contains data drawn from WIPO documents on Patent Related Flexibilities in the Multilateral Legal Framework and their Legislative Implementation at the National and Regional Levels. The database allows searches for implementation of flexibilities in national IP laws in selected jurisdictions.

banner-colors.jpg

Contribute to improve and update this page!

We particularly welcome suggestions on additional data sources. 

bottom of page
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.